NCT03115333 2026-03-02
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
Clinical Trials
8 trialsNCT02372409 2024-11-01
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Washington University School of Medicine
Phase 2 Terminated
NCT02613988 2024-05-14
Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
Asan Medical Center
Phase NA Recruiting
NCT04143425 2024-05-14
Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
Asan Medical Center
Completed
NCT05868928 2024-05-14
Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis
Asan Medical Center
Recruiting
NCT05358340 2023-05-09
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
University Health Network, Toronto
Phase NA Unknown
NCT02843230 2022-04-08
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Massachusetts General Hospital
Completed
NCT01996527 2017-04-17
3T MRI Biomarkers of Glioma Treatment Response
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Terminated